Initiative aims to generate awareness about idiopathic hypersomnia and encourage those who may be struggling with the sleep disorder to have effective discussions with their healthcare providers and ...
ATLANTA--(BUSINESS WIRE)--The HYPERSOMNIA FOUNDATION, a leading nonprofit patient advocacy group dedicated to improving the lives of people with idiopathic hypersomnia and other rare sleep disorders, ...
A recently launched campaign by Jazz Pharmaceuticals and the Hypersomnia Foundation spotlights a lack of knowledge on idiopathic hypersomnia, as well as how care teams can optimally screen for ...
Sleep is essential for a person’s health, and people who feel tired on occasion often boost their energy levels by taking a nap or ensuring restful shut-eye the next evening. But when sleep doesn't ...
Humans need sufficient sleep to function. The conventional wisdom is that we need around 8 hours each night to be at peak performance. But for people with idiopathic hypersomnia, or IH, no amount of ...
ATLANTA--(BUSINESS WIRE)--The HYPERSOMNIA FOUNDATION (HF), a leading nonprofit patient advocacy group dedicated to improving the lives of people with idiopathic hypersomnia and other rare sleep ...
Illuminate Hypersomnia Initiative Shines Light on What It's Like to Live with Idiopathic Hypersomnia
Global Community Unites to Illuminate the Challenges and Treatment Aspirations of People Living with Idiopathic Hypersomnia WEST PALM BEACH, Fla., Dec. 7, 2023 /PRNewswire/ -- The Sleep Consortium, in ...
CELEBRATION, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- KemPharm, Inc. (KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare central ...
sleep disorder, insomnia, restlessness, tired woman A survey of health care providers found a lack of knowledge on idiopathic hypersomnia (IH) among physicians, and that the disorder is often ...
It marks the second approval for Xywav. As reported by Medscape Medical News, the FDA approved it last year for the treatment of cataplexy or excessive daytime sleepiness in patients as young as age 7 ...
DUBLIN, March 18, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and the Hypersomnia Foundation today announced the launch of I Have IH, a disease awareness campaign that aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results